• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MEI

Meteoric Resources Limited - Discussion

0.93% ! 21.7¢
Market Cap $624.9M  !
Metals & Mining Industrial Metals & Minerals
Add to My Watchlist

Corporate Spotlight


View the full Corporate Spotlight arrow Created with Sketch.

Meteoric Resources Limited

edit-2 Created with Sketch. New Thread
refresh Created with Sketch. REFRESH
Forum Tag Subject View Poster Comments Created with Sketch. Views Created with Sketch. Likes Created with Sketch. Date Created with Sketch.
refresh Created with Sketch. REFRESH

Featured News

NEWS Want to reach millions of investors? Get in touch
right-arrow Created with Sketch.
NEWS Read the Latest ASX News here on HotCopper
right-arrow Created with Sketch.
NEWS Watch the Latest Video Interviews here on HotCopper
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
21.7¢ 		Change
0.002(0.93%) 		Mkt cap ! $624.9M
Open High Low Volume
21.5¢ 22.0¢ 21.5¢ 3.319M

Buyers (Bids)

Vol. Price($)
457757 21.5¢
 

Sellers (Offers)

Price($) Vol.
22.0¢ 796941
Last trade - 13.07pm 28/08/2026 (20 minute delay) ?
MEI (ASX) Chart

Top Stories

Lodestar Minerals' drilling results strengthen IOCG model at Three Saints

Lodestar Minerals has received positive final assay results for the second diamond drill hole at the Three Saints IOCG project in Chile.
Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus Askari Metals Executive Director Gino D’Anna discusses the company’s Ethiopia strategy, permitting progress, and broader portfolio ambitions.
Imricor Med and Philips launch commercial iMR lab solution Imricor Medical Systems has launched a new Interventional MR (iMR) lab solution in collaboration with Dutch company Royal Philips.
Patrys secures ethics approval for Phase 1A clinical trial on delirium candidate Patrys has received HREC approval to commence its Phase 1A clinical trial of RLS-2202 for the treatment of delirium in acute care settings.
Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27 Right now, the US-Israel-Iranian war in the Middle East and the ongoing war in Ukraine are both increasing global demand for a critical mineral vital for national security and defence: tungsten. While not the whole story of its appeal, tungsten has the highest melting point of any metal and is hi...

Featured News

NEWS Want to reach millions of investors? Get in touch
right-arrow Created with Sketch.
NEWS Watch the Latest Video Interviews here on HotCopper
right-arrow Created with Sketch.
NEWS Read the Latest ASX News here on HotCopper
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.